1. Home
  2. LYEL vs BVS Comparison

LYEL vs BVS Comparison

Compare LYEL & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$23.86

Market Cap

490.1M

Sector

Health Care

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$10.57

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYEL
BVS
Founded
2018
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
490.1M
617.1M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
LYEL
BVS
Price
$23.86
$10.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$30.60
$14.00
AVG Volume (30 Days)
76.6K
416.1K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.33
Revenue
$36,000.00
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
$16,285.34
$7.06
P/E Ratio
N/A
$29.97
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$5.81
52 Week High
$45.00
$9.98

Technical Indicators

Market Signals
Indicator
LYEL
BVS
Relative Strength Index (RSI) 56.94 74.46
Support Level $21.27 $8.43
Resistance Level $27.30 N/A
Average True Range (ATR) 1.70 0.36
MACD 0.50 0.11
Stochastic Oscillator 80.58 97.35

Price Performance

Historical Comparison
LYEL
BVS

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: